HKDC1 is identified as a promising biomarker for early cancer diagnosis, with significantly elevated expression across multiple malignancies, including gastric, lung, hepatocellular, and pancreatic cancers, correlating with tumor growth and glycolytic activity. The gene discussed is HKDC1; the disease is pancreatic neoplasm.